BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 26283479)

  • 1. The Presence and Preferential Activation of Regulatory T Cells Diminish Adoptive Transfer of Autoimmune Diabetes by Polyclonal Nonobese Diabetic (NOD) T Cell Effectors into NSG versus NOD-scid Mice.
    Presa M; Chen YG; Grier AE; Leiter EH; Brehm MA; Greiner DL; Shultz LD; Serreze DV
    J Immunol; 2015 Oct; 195(7):3011-9. PubMed ID: 26283479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
    Christianson SW; Shultz LD; Leiter EH
    Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse.
    Bobbala D; Chen XL; Leblanc C; Mayhue M; Stankova J; Tanaka T; Chen YG; Ilangumaran S; Ramanathan S
    Diabetologia; 2012 Nov; 55(11):3010-20. PubMed ID: 22890824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.
    You S; Slehoffer G; Barriot S; Bach JF; Chatenoud L
    Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent.
    Serreze DV; Chapman HD; Varnum DS; Gerling I; Leiter EH; Shultz LD
    J Immunol; 1997 Apr; 158(8):3978-86. PubMed ID: 9103469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse.
    Herbelin A; Gombert JM; Lepault F; Bach JF; Chatenoud L
    J Immunol; 1998 Sep; 161(5):2620-8. PubMed ID: 9725264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-γ Limits Diabetogenic CD8
    Driver JP; Racine JJ; Ye C; Lamont DJ; Newby BN; Leeth CM; Chapman HD; Brusko TM; Chen YG; Mathews CE; Serreze DV
    Diabetes; 2017 Mar; 66(3):710-721. PubMed ID: 27920091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD mice.
    Dwyer CJ; Bayer AL; Fotino C; Yu L; Cabello-Kindelan C; Ward NC; Toomer KH; Chen Z; Malek TR
    Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-γ receptor deficiency prevents diabetes induction by diabetogenic CD4+, but not CD8+, T cells.
    Yi Z; Li L; Garland A; He Q; Wang H; Katz JD; Tisch R; Wang B
    Eur J Immunol; 2012 Aug; 42(8):2010-8. PubMed ID: 22865049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.
    Gregori S; Giarratana N; Smiroldo S; Adorini L
    J Immunol; 2003 Oct; 171(8):4040-7. PubMed ID: 14530324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different modulation of Ptpn22 in effector and regulatory T cells leads to attenuation of autoimmune diabetes in transgenic nonobese diabetic mice.
    Yeh LT; Miaw SC; Lin MH; Chou FC; Shieh SJ; Chuang YP; Lin SH; Chang DM; Sytwu HK
    J Immunol; 2013 Jul; 191(2):594-607. PubMed ID: 23752610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoid hyperplasia, CD45RBhigh to CD45RBlow T-cell imbalance, and suppression of Type I diabetes mellitus result from TNF blockade in NOD-->NOD-scid adoptive T cell transfer.
    Brown GR; Silva MD; Thompson PA; Beutler B
    Diabetologia; 1998 Dec; 41(12):1502-10. PubMed ID: 9867218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice.
    Rohane PW; Shimada A; Kim DT; Edwards CT; Charlton B; Shultz LD; Fathman CG
    Diabetes; 1995 May; 44(5):550-4. PubMed ID: 7729614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paralytic autoimmune myositis develops in nonobese diabetic mice made Th1 cytokine-deficient by expression of an IFN-gamma receptor beta-chain transgene.
    Serreze DV; Pierce MA; Post CM; Chapman HD; Savage H; Bronson RT; Rothman PB; Cox GA
    J Immunol; 2003 Mar; 170(5):2742-9. PubMed ID: 12594305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8 cytotoxic T-cell clone rapidly transfers autoimmune diabetes in very young NOD and MHC class I-compatible scid mice.
    Yoneda R; Yokono K; Nagata M; Tominaga Y; Moriyama H; Tsukamoto K; Miki M; Okamoto N; Yasuda H; Amano K; Kasuga M
    Diabetologia; 1997 Sep; 40(9):1044-52. PubMed ID: 9300241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
    Kanagawa O; Militech A; Vaupel BA
    J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
    Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
    Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
    Mukherjee R; Chaturvedi P; Qin HY; Singh B
    J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
    Mellanby RJ; Thomas D; Phillips JM; Cooke A
    Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes.
    Balasa B; Van Gunst K; Sarvetnick N
    Clin Immunol; 2000 May; 95(2):93-8. PubMed ID: 10779402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.